Anaemia is a chief determinant of global ill health, contributing to cognitive impairment, growth retardation and impaired physical capacity. To understand further the genetic factors influencing red blood cells, we carried out a genome-wide association study of haemoglobin concentration and related parameters in up to 135,367 individuals. Here we identify 75 independent genetic loci associated with one or more red blood cell phenotypes at P , 10
Haemoglobin, an iron-containing metalloprotein found in the red blood cells of all vertebrates, provides the primary mechanism for oxygen transport in the circulation. Haemoglobin levels and related red blood cell phenotypes are tightly regulated, including an important genetic component [1] [2] [3] [4] [5] . To refine our understanding of the genetic factors influencing red blood cell formation and function, we carried out a meta-analysis of genome-wide association studies (GWAS) and staged follow-up genotyping of six red blood cell phenotypes: haemoglobin, mean cell haemoglobin (MCH), mean cell haemoglobin concentration (MCHC), mean cell volume (MCV), packed cell volume (PCV) and red blood cell count (RBC).
Our study design is summarized in Supplementary Fig. 1 . In brief, we combined genome-wide association data from 71,861 individuals of European or South Asian ancestry, with up to 2,644,161 autosomal single-nucleotide polymorphisms (SNPs) and 67,645 X-chromosome SNPs. Characteristics of participants, genotyping arrays and imputation are summarized in Supplementary Tables 1-3 . Meta-analysis was carried out among Europeans and South Asians separately, followed by a final combined analysis of results from the two populations. We performed replication testing of 22 loci showing suggestive association (10 28 , P , 10 27 ) in a further 63,506 individuals using a combination of in silico data and direct genotyping (Supplementary  Tables 1, 2 and Supplementary Note). Genome-wide significance was set at P , 1 3 10 28 , allowing a Bonferroni correction both for the , 10 6 independent SNPs tested 6 , as well as for the six inter-related red blood cell phenotypes (Supplementary Note) 7 . Seventy-five independent genetic loci reached genome-wide significance for association with one or more red blood cell phenotypes (Table 1 and Supplementary Fig. 2 ), 43 of which are novel. For descriptive and downstream purposes, we identified a single 'sentinel' SNP for each of the 75 loci, defined as the SNP with the lowest P value against any phenotype at each locus; regional plots for the 75 loci are shown in Supplementary Fig. 3 . Full lists of the SNPs associated with phenotype at P , 10 26 and of the sentinel SNPs are provided (Supplementary Tables 4 and 5 ). Of the 38 loci previously reported to be associated with red blood cell traits [1] [2] [3] [4] [5] , we replicate 32 loci (P , 10 28 ) and find three to be nominally associated (P , 0.05; Supplementary Table 6 ). The remaining three loci, initially reported in an East Asian GWAS 4 , were not associated with red blood cell phenotypes in our sample (Supplementary Fig. 4 and Supplementary Note). Among the 75 genomic loci identified, we found that 31 were associated with one red blood cell phenotype, and 44 with two or more phenotypes, at P , 10
28 . The total number of locus-phenotype associations identified at P , 10 28 was 156, of which 92 are novel (Supplementary Fig. 5 and Supplementary Table 7 ). In addition, at 8 of the 75 loci we found evidence for multiple SNPs independently associated with red blood cell phenotype at P , 10 28 in conditional analyses 8 , suggesting the presence of possible secondary genetic mechanisms at these loci (Supplementary Table 8 ).
Identification of candidate genes
There are .3,000 protein-coding genes within 1 megabase (Mb) of the sentinel SNPs from the 75 genetic loci associated with red blood cell phenotypes. We prioritized genes as probable candidates underlying the observed genetic associations using the following criteria: (1) gene nearest to the sentinel SNP, and any other gene within 10 kilobases (kb) (97 genes; Table 11 ). This strategy identified 121 candidate genes (Table 1 and Supplementary Fig. 6 ).
Pathway analysis revealed that the list of candidate genes is strongly enriched for genes known to be involved in haematological development and function (P 5 10
263
), as well as in cellular proliferation, development and death, and immunological processes (Supplementary Tables 12 and 13 ). Current knowledge of gene function for all 121 candidates is summarized in Supplementary Table 14 . Of note, some of the genes within these regions are known to underlie the Mendelian red blood cell disorders of elliptocytosis, ovalocytosis and spherocytosis (ANK1, SLC4A1, SPTA1) 10 , haemolytic anaemia (HK1) 11 and iron deficiency or overload (TMPRSS6, HFE, TFR2)
12
. Furthermore, somatic mutations of IKZF1, KIT, SH2B3, SH3GL1 and TAL1 (also known as SCL) underlie several haematologic proliferative disorders (Supplementary Table 14) . 
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Gene expression during haematopoiesis
We next explored expression of the 121 candidate genes using an atlas of 38 different haematopoietic cell types (Supplementary Table 15) 13 . Ninety-seven genes could be reliably assigned a probe on the Affymetrix HG_U133AAofAv2 array (Fig. 1a) ; these transcripts were, on average, expressed at higher levels in late erythroblasts (or the precursors of red blood cells, EB3-EB5) compared to other transcripts in the same cell type (P , 0.01 after Bonferroni correction; Fig. 1b) . Furthermore, expression was more likely to be upregulated in EB3-5 relative to other cell types (P 5 1.2 3 10 26 , rank-sum test). To further investigate lineage-specific effects, we assessed temporal patterns of gene expression during in vitro differentiation of haematopoietic stem cells to erythroblasts 14 . On average, candidate genes have increasing expression over time along the erythroid lineage (P 5 0.006, rank-sum test; Fig. 1c ). These data support the view that the gene set identified here is enriched for genes relevant to red blood cell biology, including a number of candidate genes differentially regulated to increase their expression in late erythropoiesis.
Coding and regulatory sequence variants
To better capture common sequence variation at the 75 loci, we searched the 1000 Genomes Project data set (www.1000genomes.org) and identified 39 non-synonymous SNPs that are in high linkage disequilibrium (r 2 . 0.8) with sentinel SNPs at the red blood cell loci (Supplementary Table 9 ). This represents a ,sixfold enrichment compared to the expectation under the null hypothesis (P 5 0.01; Supplementary Note). Although re-sequencing will be needed to obtain a complete assessment of variants at these loci, these nonsynonymous sites represent an initial set of candidates for genetic variants underlying the observed associations with red blood cell phenotypes, potentially mediated through changes in protein function.
We next searched for sequence variants at the red blood cell loci that might influence gene regulation. We used formaldehyde-assisted isolation of regulatory elements followed by next-generation sequencing (FAIRE-seq) to identify nucleosome-depleted regions (NDRs) that may represent active regulatory elements 15 . We studied three haematologic cell types, and found 103,308 unique NDRs, of which 38,014 were present in erythroblasts, 50,372 in megakaryocytes and 34,833 in monocytes. We then searched the 1000 Genomes Project data set and found 60 SNPs located within one of these NDRs that are either: (1) one of the 75 sentinel SNPs from the red blood cell GWAS, or (2) in high linkage disequilibrium (r 2 . 0.8) and located within 1 Mb of a sentinel SNP (Supplementary Table 16 ). The NDRs overlapping these 60 SNPs were more likely to be erythroblast specific than expected by EB5  EB4  EB3  EB2  EB1  MEP  CMP  HSC2  HSC1  MK1  MK2  GMP  BASO  EOS  GRAN1  GRAN2  GRAN3  MONO1  MONO2  PreBCELL1  PreBCELL2  DEND1  DEND2  BCELL1  BCELL2  BCELL3  BCELL4  NK1  NK2  NK3  NKT  TCELL1  TCELL2  TCELL3  TCELL4  TCELL5  TCELL6  TCELL7   ATP2B4  OR10Z1  NUTF2  PGS1  SLC17A3  NEK8  NPRL3  HFE  NUDT19  NRIP3  C17orf69  CORO1B  OR6Y1  ATP5O  STH  SPECC1  RPS6KB2  PSMB10  P2RY6  ODF3B  LIPC  KITLG  KIT  KCTD17  HIST1H3J  FBXO7  EIF5  DENND4A  CCND2  CCNA2  CCDC27  CCDC162P  CALR  CACNA1C  BBS7  ABO  ATXN2  MLEC  RCL1  C11orf16  LRRC48  PRKCE  HIST1H2BO  HIST1H2AM  HLA−DQA1  ST5  FARSA  SCAMP5  QKI  SLC4A1  ANK1  SMOC1  ARHGAP27  SPPL2C  C17orf63  ARHGEF17  DNAJA4  RPP21  AP3D1  RASA2  C18orf25  ACTL6B  SH3GL1  SCO2  SBF2  RBM38  PTPRCAP  NRG4  NKX2−3  NEUROD2  NCAPH2  MAPT  KANSL1  IKZF1  HLA−DQA2  HEYL  HBS1L  FNTB  ERAL1  EDC4  CTRL  CDK12  CCND3  C8orf40  ACOXL  BCL11A  PRKAG2  AKIP1  CITED2  GMPR  CRHR1  PTPLAD1  HK1  PPCDC  MAX  SPTA1  MARCH8 . Cell acronyms refer to original source (summarized in Supplementary Table 15) . Expression above a log 2 signal intensity (SI) of 6 is consistently above background. b, 2log 10 P of the signedrank test for candidate genes being more highly expressed in each cell type than non-candidate genes. c, Time-course of differentiation of cord-blood haematopoietic stem cells cultured along the erythroid lineage. Putative candidate genes are shown as upregulated (red), downregulated (blue) or with the slope not being significantly different from zero (grey). d, Tissue distribution of NDRs containing a potential causal variant. NDRs were ranked by peak score (proportional to their peak height in FAIRE-seq). The rankings were then used to divide the NDRs into cumulative tranches to explore the effect of callingthresholds on results (left bar, tranche containing the 5,000 top-ranked NDRs of each cell type; penultimate bar, tranche containing the 50,000 top-ranked NDRs of each cell type). The solid line indicates the number of SNPs overlapping the tranche-specific NDRs that are potential causal variants (defined as a sentinel SNP from the red blood cell GWAS, or a SNP in high linkage disequilibrium (r 2 . 0.8) and located within 1 Mb of a sentinel SNP; right-hand y axis); the bar summarizes the tissue distribution of these SNPs (as a percentage of tranchespecific total). The right-hand bar represents the expected tissue distribution for the SNPs under the null hypothesis. Results show that the potential causal variants are most commonly found in erythroblast-specific NDRs, and that this is true across the spectrum of peak-calling thresholds.
ARTICLE RESEARCH
chance (1.8-fold enrichment compared to background distribution of NDRs; P 5 0.007, Bonferroni-adjusted binomial test); by contrast, there were fewer megakaryocyte-specific NDRs coinciding with red blood cell SNPs (0.4-fold enrichment; P 5 0.007; Fig. 1d ). This pattern of erythroblast enrichment and megakaryocyte depletion was robust to the stringency of NDR peak-calling (Supplementary Table 17 ). Our results indicate that regulatory variation within the erythroid lineage may underlie the associations observed at several of the loci identified in our red blood cell GWAS. The 19 genes closest to the 25 erythroblast-specific NDRs were more likely to be upregulated during erythropoiesis compared to all other expressed transcripts (P 5 6.33 10
26
, rank-sum test; Supplementary Table 18) , lending further support to the view that the NDRs identified have a role in the regulation of genes involved in erythropoiesis 16, 17 . Interestingly, the SNPs associated with MCH at 16p11 overlap an erythroblast-specific NDR that coincides with the NPRL3 regulatory element in the locus control region of the downstream haemoglobin-a locus 18, 19 . Together our coding-and regulatory-variant analyses thus identify a set of ,100 SNPs across 41 regions that are candidates for functional genomic elements influencing red blood cell formation and function, and which constitutes a priority set for future experimental evaluation.
Insights from mouse models
A systematic search of the Mouse Genome Informatics database reveals haematologic phenotypes for 29 of the 100 candidate genes that have mouse homologues (Supplementary Fig. 6 and Supplementary Tables 14, 19 ), including genes involved in cell cycle regulation: CCNA2 (4q27), CCND2 (12p13) and CCND3 (6p21); genes coding for transcription factors and their interacting proteins: BCL11A (2p16), CITED2 (6q24), IKZF1 (7p13) and TAL1 (1p32); and genes involved in growth factor or cytokine signalling: KIT (4q11), KITLG (12q22), SH2B3 (12q24) and PTPRCAP (11q13). Among the gene products encoded at the newly identified loci, KITLG, also known as stem cell factor, is the cognate ligand for the KIT tyrosine kinase receptor 20 . KIT signalling is involved in the perinatal transition from fetal to adult haemoglobin, in addition to maintenance, proliferation and differentiation of haematopoietic stem cells 21 . Kitlg 2/2 and Kit 2/2 mice have low red blood cell concentrations, anaemia and other haematological abnormalities. CCNA2, CCND2 and CCND3 are cyclin-dependent kinases that contribute to initiation and progression of cell division 22 . Knock-out models of these genes have a number of haematological abnormalities, including reduced stem cell and red blood cell concentrations, and anaemia 22 . Of the 29 candidate genes with a blood phenotype in mouse, 25 were identified as the genes nearest to the sentinel SNP, and 15 through the eQTL (n 5 2), coding-variant (n 5 6) or GRAIL (n 5 8) analyses (Supplementary Table 19 ).
RNAi silencing in D. melanogaster
We used haemocyte-specific RNA interference (RNAi) silencing in D. melanogaster to further evaluate the candidate genes for their role in blood cell formation. We first carried out permutation testing in a genome-wide D. melanogaster RNAi silencer screen (Supplementary Note). Results confirmed that the 121 candidates are enriched for genes with a blood cell phenotype in D. melanogaster, supporting the view that our GWAS identifies a set of genes conserved across phyla and involved in blood cell formation or survival.
We next created haemocyte-specific RNAi knockdowns for 96 D. melanogaster genes that are orthologues for 74 of the 121 candidate genes, and assessed blood cell formation (crystal cells and plasmatocytes) in early-and late-stage L3 larvae 23 . We found 19 out of the 74 candidate genes with orthologues in D. melanogaster to have a blood cell phenotype, of which 5 also have a haematological phenotypes in mouse models: KIT, HK1, CCNA2, AP3D1 and PSMB10 (Supplementary Tables 19 and 20) . Among the genes highlighted, RNAi silencing of KIT and CCNA2 orthologues was associated with a profound reduction in plasmocyte formation (Fig. 2) , consistent with their established role in cytokinesis 20, 22 . AP3D1 is involved in vesicular trafficking and dense granule formation in platelets 24 , whereas PSMB10 is a component of a widely distributed proteasome linked to inflammation and ubiquitin signalling 25 . UBE2L3 is also involved in ubiquitin signalling and immune regulation 26 , and genetic variants in UBE2L3 are strongly associated with several autoimmune diseases known to influence blood cell counts 27,28 . EIF5 (14q32) is involved in activation of the ribosomal initiation complex 29 , whereas RPS6KB2 (22q11) is a key component of growth factor and other signalling cascades that regulate ribosomal function, cellular proliferation and survival 30 . For most of the genes identified, the mechanisms underlying their potential relationship to red cell biology remain to be elucidated; our gene set thus provides a rich resource for future experimental evaluation and discovery.
Contribution to clinical phenotype
The 75 sentinel SNPs together account for between 3.9% (PCV) and 8.9% (MCV) of population variation in red blood cell phenotypes (Supplementary Table 21 ). Individuals in the highest quartile of genetic risk score (GRS; on the basis of weighted effect of the 75 sentinel SNPs) are 3-5-fold more likely to be in the highest quartile for population distribution of MCH, MCV and RBC (Fig. 3) . GRS is associated with haemoglobin concentrations across the physiological range, including at haemoglobin levels that predict adverse outcomes in pregnancy, cardiovascular and neurologic disease, in addition to mortality in the elderly 31-34 . We next investigated the association of the 75 sentinel SNPs with red blood cell phenotypes in thalassaemia, a group of genetic disorders characterized by defects in haemoglobin synthesis and anaemia. We confirmed association of several of the sentinel SNPs with respective blood cell trait, and found that GRS predicts phenotype similarly, among 460 b-thalassaemia heterozygotes (Supplementary Table 22 and Supplementary Note). In separate experiments, GRS predicts time to first blood transfusion among 495 patients with thalassaemia major (P 5 6.9 3 10 24 ); however, this effect was fully accounted for by the MYB-HBS1L locus, which modifies the severity of thalassaemia major RESEARCH ARTICLE through its effect on fetal haemoglobin levels (Supplementary Note) 35 . Together, our findings demonstrate that the common genetic variants identified contribute to phenotypic variation in the general population, and suggest that they may also act as genetic modifiers in clinically relevant red blood cell abnormalities.
Conclusions
Our genome-wide association and replication study in 135,367 individuals identifies 75 genetic loci influencing red blood cell phenotypes, and 156 locus-phenotype associations; most of these discoveries are novel. Through open-chromatin and coding-variant studies, we identify a first set of SNPs as potential causal variants. In parallel, our bioinformatic strategies identify a core set of genes, differentially regulated in haematologic precursor cells, which are candidates for mediating the effects onred blood cell phenotypes. However, despite our extensive GWAS, bioinformatic and experimental data, the precise identities of the causal variants, regulatory regions and genes remain to be determined; definitive identification will require further detailed experimental evaluation. Our results thus provide new insights into the genes and gene variants that may influence haemoglobin levels and related red blood cell indices, and will underpin a deeper knowledge of the biological mechanisms involved in haematopoiesis and red blood cell function.
METHODS SUMMARY
Genome-wide association and replication. Genome-wide association was carried out in 62,553 people of European ancestry and 9,308 people of South Asian ancestry. Phenotypic associations were tested in each cohort separately, followed by fixed-effect meta-analysis using Z-scores weighted by the square root of sample size. Replication testing of 22 SNPs was done by in silico and direct genotyping among 63,506 people, and results combined with genome-wide association data. Genome-wide significance was inferred at P , 1 3 10
28
. Gene-expression profiling. Gene expression was investigated in cord-bloodderived CD34
1 haematopoietic stem cells in vitro, differentiated along the erythroid lineage for 3, 5, 7, 9 or 10 days. Gene expression was assayed using Illumina human WGv3.0 microarrays, and temporal patterns quantified by linear regression. Open-chromatin studies. FAIRE-seq was done in erythroblasts, megakaryocytes and peripheral blood monocytes. NDRs were identified as regions of sequencing enrichment using F-Seq 36 . Candidate functional SNPs were selected as all biallelic SNPs within 1 Mb of the sentinel SNP and in linkage disequilibrium at r 2 . 0.8. D. melanogaster studies. D. melanogaster orthologues of the human candidate genes were identified using Ensembl Compara. Haemocyte-specific RNAi silencing of the orthologues identified was achieved using the blood-specific hemolectin promoter driving the yeast transcriptional activator Gal4 (HmlGal4) which, in turn, promotes upstream activation sequence-short hairpin RNA expression. Early and late L3 larvae were analysed for plasmatocyte and crystal cell numbers and morphology. Contribution to population variation. Phenotypic contribution was investigated in non-discovery samples. Estimates of population variance explained by the sentinel SNPs were made in each study separately, and mean values calculated weighted by sample size. We calculated the odds ratio for being in the highest versus the lowest quartile of phenotype, associated with a SNP score defined as the sum of number of effect (trait raising) alleles present, weighted according to effect size.
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METHODS
Genome-wide association. Genome-wide association was carried out in 62,553 people of European ancestry and 9,308 people of South Asian ancestry, using up to 2,644,161 autosomal and 67,645 X-chromosome SNPs. Imputation was done using haplotypes from HapMap Phase 2. Characteristics of participants, genotyping arrays and imputation are summarized in Supplementary Tables 1 and 2 . Participants with extreme measurements (. 6 3 s.d. from mean) were excluded on a per-phenotype basis. Each population cohort was approved by a research ethics committee, and all participants gave informed consent.
SNP associations with each phenotype were tested by linear regression using an additive genetic model. Associations were tested separately in men and women in each cohort, with principal components and other study-specific factors as covariates to account of population substructure as described in Supplementary  Table 2 . Test statistics from each cohort were then corrected for their respective genomic-control inflation factor to adjust for residual population sub-structure; genomic-control inflation factors are summarized in Supplementary Table 3 . We then carried out a meta-analysis of results from the individual cohorts using Z-scores weighted by the square root of sample size. The meta-analysis was varied out among Europeans and South Asians separately. There were no South-Asianspecific discoveries, but also little evidence for heterogeneity of effect at known or new genetic loci (Supplementary Table 23) ; we therefore carried out a final combined analysis of results for the two populations. SNPs with minor allele frequency ,1% (weighted average across cohorts) were removed, as were SNPs with weight ,50% of phenotype sample size. There was no evidence for inflation of test statistics at SNPs not known to be associated with red blood cell phenotypes (Supplementary Table 3 ), and genomic control was not applied to the final meta-analysis results. We used the function 'clump' implemented in PLINK to cluster the SNPs into genomic loci using a 2-Mb window; clustering was done separately for each phenotype. Inverse variance meta-analysis was used to quantify effect sizes for SNPs of interest.
Genome-wide significance was inferred at P , 1 3 10 28 . This choice of statistical threshold was grounded on the guidelines derived from studies of the ENCODE (encyclopedia of DNA elements) regions 6 , combined with results of permutation testing to determine the additional adjustment needed for the six red blood cell phenotypes studied (Supplementary Tables 24, 25 and Supplementary Note). As an alternative strategy, a P-value threshold of P , 3.2 3 10 29 would provide correction for the number of SNP-phenotype combinations tested without any adjustment for the correlations between the SNPs or phenotypes tested. We note that 70 of the 75 loci identified would exceed such a highly stringent threshold, including all four of the loci identified through the joint analysis of European and South Asian data. Replication testing. We carried out replication testing of 22 SNPs selected on the basis of the following criteria: (1) the lead SNP from each of 17 loci showing suggestive evidence for association with one or more red blood cell phenotypes in Europeans (P . 10 28 and P , 10 27 ), and (2) the lead SNP from each of the loci identified through combined analysis of genome-wide association data for Europeans and South Asians. Replication testing was done using a combination of in silico results and direct genotyping among 63,506 people from four population cohorts.
In silico data were available for 34,843 people from Iceland participating in the deCODE (diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe) study 37 (Supplementary Table 1 ). SNPs were directly genotyped with the Illumina HumanHap300 or CNV370 chips or imputed from one or more of four sources: the HapMap2 CEU sample (60 triads), the 1000 Genomes Project data (179 individuals) and Icelandic samples genotyped with the Illumina Human1 M-Duo (123 triads) or the HumanOmni1-Quad chips (505 individuals), as previously described in ref. 37 . The 22 SNPs were tested for association against their respective discovery phenotypes, under an additive genetic model; results were combined with the genome-wide association data by weighted-Z-score metaanalysis.
We found that for 7 of the 22 SNPs carried forward for replication, their associations with phenotype remained inconclusive after in silico testing (P . 10 28 but P , 10
27
). For these SNPs we carried out additional direct genotyping using Sequenom assays, among up to 20,066 people from three population cohorts (Supplementary Table 1 ). Associations were tested in each cohort separately, and results combined across the replication cohorts, and then with the genome-wide association data, by weighted-Z-score meta-analysis (Supplementary Table 26 ). Conditional analysis. We performed conditional-association analysis using the summary statistics from the meta-analysis to test for the association of each SNP while conditioning on the top SNPs, with correlations between SNPs due to linkage disequilibrium estimated from the imputed genotype data from the atherosclerosis risk in communities (ARIC) cohort 8, 38 . Secondary-association signals were selected with conditional-association P , 1 3 10 28 .
Identification of candidate genes. We considered the nearest gene, and any other gene located within 10 kb of the sentinel SNP, to be a candidate for mediating the association with red blood cell phenotype. We also used coding variant, eQTL and literature analyses to identify candidate genes. On the basis of analysis of linkage-disequilibrium relations at the 75 genetic loci, we defined genomic region as the 1-Mb interval either side of the sentinel SNP for our functional genomic studies ( Supplementary Fig. 7 ). Coding variation. We identified all non-synonymous SNPs that were in linkage disequilibrium with one or more of the sentinel SNPs at r 2 . 0.8 in 1000 Genomes Project data set (released in March 2012). We considered the gene to be a candidate when the non-synonymous and sentinel SNPs were in linkage disequilibrium at r 2 . 0.8 and with no evidence for heterogeneity of effect on phenotype. This strategy identified 39 non-synonymous SNPs distributed between 24 genes (Supplementary Table 9 ), representing a ,sixfold enrichment compared to the mean number expected under the null hypothesis generated by permutation testing of SNP sets matched for allele frequency (6 0.05) and number of genes in proximity (6 10 kb), but selected otherwise at random (P 5 0.01; Supplementary Note). Expression analyses. To identify the possible genes influencing red blood cell phenotypes at the 75 loci, we examined the association of the sentinel SNPs with eQTL data from two data sets: (1) peripheral blood lymphocytes from 206 families of European descent (830 parents and offspring) 39 and (2) peripheral blood lymphocytes from 1,469 unrelated individuals 40 . SNPs were tested for association with expression of nearby (1 Mb) genes (P , 0.05 after Bonferroni correction for number of SNP-transcript associations tested). Where eQTLs were identified, we used the whole-genome SNP data available in these data sets (imputed with HapMap Phase 2 genotypes), to identify the SNP at the locus most closely associated with transcript level (the transcript SNP). We then tested whether the sentinel SNP and the transcript SNP were coincident, defined as r 2 . 0.8 with no evidence for heterogeneity of effect on phenotype or transcript level (P . 0.05). This strategy identified eQTLs involving 28 genes from 18 loci (Supplementary Table 10 ). GRAIL analyses. We carried out a literature analysis using the GRAIL algorithm 9 , a statistical tool that uses text mining of PubMed abstracts to annotate candidate genes from loci associated with phenotypic traits. We carried out the analysis using the 2006 data set to avoid confounding by subsequent GWAS discoveries; results identified candidate genes at nine loci (P , 0.05; Supplementary Table 11 ). Results are also shown for a GRAIL analysis using the 2011 PubMed data set, although these were not used for the final analysis. Gene expression in haematopoietic precursors. Cord-blood-derived CD34 1 haematopoietic stem cells were differentiated in vitro along the erythroid lineage in the presence of 6 U ml 21 erythropoietin (R&D Systems), 10 ng ml 21 interleukin (IL)-3 (Miltenyi Biotec) and 100 ng ml 21 stem cell factor (R&D Systems). Cells were collected at days 3, 5, 7, 9 and 10 in three biological replicates and gene expression was assayed using Illumina human WGv3.0 microarrays 41 . For each gene, we determined the relationship of gene expression with time using linear regression, and calculated the t-statistic for the difference in b from zero. We then classified gene-expression patterns as increasing, decreasing or unchanged on the basis of the 2.5% and 97.5% quartiles of the t distribution with 4 degrees of freedom. To test whether a gene set was enriched for differentially regulated genes, a Wilcoxon signed-rank test of the t scores in the gene set relative to all others genes that were expressed in at least one time point was calculated. FAIRE-seq. We generated maps of chromatin accessibility ('open chromatin') in primary human erythroblasts and megakaryocytes, and in peripheral blood monocytes using FAIRE-seq. Cord-blood-derived CD34
1 haematopoietic progenitor cells from two unrelated individuals were differentiated in vitro into either erythroblasts (in the presence of erythropoietin, IL-3 and stem cell factor) or megakaryocytes (in the presence of thrombopoietin and IL-1b). Monocytes were purified from leukocyte cones of apheresis collections from another two individuals.
FAIRE experiments were performed as previously described in ref. 42 . FAIRE DNA was processed following the Illumina paired-end library-generation protocol. Genomic libraries derived from erythroblast and megakaryocyte cultures were sequenced with 54-bp paired-end reads on Illumina Genome Analyzer II. Libraries derived from monocyte extractions were sequenced with 50-bp pairedend reads on Illumina HiSeq. Raw sequence reads were aligned to the human reference sequence (NCBI build 37) using the read mapper Stampy 43 . Reads were realigned around known insertions and deletions, followed by base-quality recalibration using the Genome Analysis Toolkit (GATK) 44 . Duplicates were flagged using the software Picard (http://picard.sourceforge.net/) and excluded from subsequent analyses. For each cell type, we merged all read fragments into one data set. NDRs were identified as regions of sequencing enrichment (peaks) using the software F-Seq 36 . We applied a feature length of L 5 600 bp and a s.d. threshold of T 5 8.0 over the mean across a local background. In order to reduce RESEARCH ARTICLE
